August 29, 2023 – Page 17

Interim condensed consolidated financial statements for the six-month period ended 30 June 2023

Written by Customer Service on August 29, 2023. Posted in Earnings Releases And Operating Results.

We are delighted and proud to present the interim condensed consolidated financial statements for the six-month period ended 30 June 2023 You can download the report available in English only. Attachment UPG-Financial_Statement_H1-2023 FINAL incl review report

Unifiedpost grows digital revenue while further improving operational efficiency

Written by Customer Service on August 29, 2023. Posted in Earnings Releases And Operating Results.

Capturing digital trends and navigating the evolving e-invoicing and e-payment market La Hulpe, Belgium – August 29, 2023, 7:00 a.m. CET – [INSIDE INFORMATION] Today, Unifiedpost Group (Euronext: UPG), a leading provider of integrated business communications solutions, presents its results for H1 2023. The digital processing revenue has increased, showing a 9,9% growth y/y, supported by a 12,3% rise in recurring digital processing revenue. This is reflected in Unifiedpost’s growing customer base, totalling 1.172.197 businesses by the end of H1 2023. As Europe continues its shift towards full digital invoicing, with some countries taking more time to adapt, the Group’s focus remains on a positive cash flow while continuing a trajectory filled with growth and innovation. Highlights Digital processing revenue grows 9,9% in H1 2023 y/y,...

Ad hoc announcement: GAM Holding AG concludes successful discussions with NewGAMe

Written by Customer Service on August 29, 2023. Posted in Public Companies.

29 August 2023 PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM Holding AG concludes successful discussions with NewGAMe GAM Holding AG (“GAM”) Board of Directors (“GAM Board”) has reached agreement with NewGAMe and Rock Investment SAS (“Rock”) to extend immediate short-term financing of CHF 20 million to cover GAM’s liquidity needs. Rock is a French-incorporated entity that is owned by NJJ Holding (“NJJ”), the personal holding company of Xavier Niel. It is part of the NewGAMe group of investors consisting of NewGAMe SA and Bruellan SA. This short-term financing will remain until it is replaced by the proceeds of a convertible bond to be issued by GAM in an amount of about CHF 25 million. The creation of the conditional capital required for the issuance of the convertible bond will be proposed...

Faron Reports Half-Year Financial Results, January 1 – June 30, 2023

Written by Customer Service on August 29, 2023. Posted in Earnings Releases And Operating Results.

Summary Highlights (including post-period events) The US Food and Drug Administration (FDA) granted bexmarilimab Orphan Drug Designation (ODD) for the treatment of acute myeloid leukemia (AML). The latest data from the Phase I/II BEXMAB study reinforces bexmarilimab’s potential to improve the therapeutic benefit for patients with aggressive hematological malignancies who do not respond to the current standard of care (SoC). Compelling data with objective responses were observed in three of five patients in the 6 mg/kg bexmarilimab + azacitidine doublet cohort. Eight of fifteen objective responses were observed across all three doublet dosing cohorts, with one patient still on treatment after 13 months. Continued efficacy signals with the prolonged duration of responses thus far support advancement to Phase II in Q4 2023 in relapsed/refractory...

Camping Tent Market Set to Soar Past USD 7.9 Billion by 2030 | Skyquest Technology

Written by Customer Service on August 29, 2023. Posted in Mergers And Acquisitions.

The global Camping Tent market size is expected to reach USD 7.9 billion by 2030 and exhibit a CAGR of 8.8% in the forecast period (2023−2030), according to Skyquest’s latest research report. The rising popularity of outdoor recreational activities, increasing interest in camping and adventure tourism, growing demand for lightweight and compact camping equipment, expanding camping and outdoor festivals, rising disposable income and consumer spending on leisure activities, technological advancements in camping tent materials and designs, growing awareness of eco-friendly and sustainable camping practices, are fueling the Market’s growth. Westford, USA, Aug. 28, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Camping Tent market, increasing demand for lightweight and ultralight camping...

Passive Fire Protection Coatings Market Set to Soar Past USD 6 Billion by 2030

Written by Customer Service on August 29, 2023. Posted in Mergers And Acquisitions.

The global Passive Fire Protection Coatings market size is expected to reach USD 6 billion by 2030 and exhibit a CAGR of 4% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing stringency of fire safety regulations, growing awareness of the importance of fire protection in buildings and infrastructure, rising demand for fire-resistant materials and systems, advancements in fire protection technologies and materials, rising adoption of passive fire protection measures in industrial settings, are fueling the Market’s growth. Westford USA, Aug. 28, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Passive Fire Protection Coatings market, increasing use of intumescent coatings for enhanced fire protection, growing demand for water-based and...

MINILUXE REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF 2023. Reported figures in U.S. Dollars

Written by Customer Service on August 29, 2023. Posted in Public Companies.

Announces Continued Double-Digit Growth with Same-Studio Revenue +23% vs. Pre-COVID (2019) Results Toronto, Ontario, Aug. 28, 2023 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX) today announced its financial results for the 13 weeks ended July 2, 2023 (“Q2 2023”) and the 26 weeks ended July 2, 2023 (“H1 2023”). The fiscal year of MiniLuxe is a 52-week reporting cycle ending on the Sunday closest to December 31, which periodically necessitates a fiscal year of 53 weeks. FY2022 consisted of a 53-week period while all other fiscal years referred to in this release consist of 52-week periods. All quarters referred to in this release consist of 13-week periods. Unless otherwise specified, all amounts are reported in U.S. dollars. MiniLuxe is pleased to announce continued double-digit growth in year-over-year (“YOY”) revenue...

Flow Capital Announces Q2 2023 Financial Results and CFO Transition

Written by Customer Service on August 29, 2023. Posted in Public Companies.

Book Value of $1.18 per share; up 29% over the past four-quarters. TORONTO, Aug. 28, 2023 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital” and “Company”), a leading provider of flexible growth capital and alternative debt solutions, announces its unaudited financial and operating results for the quarter ending June 30, 2023 (“Q2 2023”). Financial references are in Canadian dollars unless otherwise specified. Q2 2023 Highlights Royalty and loan interest income of $1.84 million, up 9.0% quarter over quarter. Recurring Royalty and Loan Interest Income1 of $1.45 million in Q2, down 4.2% quarter over quarter. Recurring Free Cash Flow2 of approx. $127,000 in Q2; and $726,000 over the past four-quarters. Total assets of approximately $58.9 million compared to $51 million at Q2 2022. Cash of over $7.7 million compared to...

HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer

Written by Customer Service on August 29, 2023. Posted in Public Companies.

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Aug. 28, 2023 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the Center for Drug Evaluation of China’s National Medical Products Administration (“NMPA”) has granted Breakthrough Therapy Designation (“BTD”) to savolitinib for the treatment of locally advanced or metastatic gastric cancer or gastroesophageal junction (“GEJ”) adenocarcinoma patients with mesenchymal epithelial transition factor (“MET”) amplification who have failed at least two lines of standard therapies. The study of savolitinib is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and tolerability of savolitinib in treating gastric cancer or GEJ adenocarcinoma patients with MET amplification. Primary...

Day: August 29, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice